Hims & Hers Health (HIMS) Competitors $26.20 -0.16 (-0.61%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends HIMS vs. NTRA, FMS, GH, OPCH, SHC, VCYT, BTSG, LFST, SGRY, and CONShould you be buying Hims & Hers Health stock or one of its competitors? The main competitors of Hims & Hers Health include Natera (NTRA), Fresenius Medical Care (FMS), Guardant Health (GH), Option Care Health (OPCH), Sotera Health (SHC), Veracyte (VCYT), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Surgery Partners (SGRY), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry. Hims & Hers Health vs. Natera Fresenius Medical Care Guardant Health Option Care Health Sotera Health Veracyte BrightSpring Health Services LifeStance Health Group Surgery Partners Concentra Group Holdings Parent Natera (NASDAQ:NTRA) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, earnings, analyst recommendations, community ranking, dividends, risk, institutional ownership, profitability and valuation. Which has higher earnings & valuation, NTRA or HIMS? Hims & Hers Health has lower revenue, but higher earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatera$1.53B13.95-$434.80M-$1.76-91.98Hims & Hers Health$1.24B4.61-$23.55M$0.4459.55 Which has more risk and volatility, NTRA or HIMS? Natera has a beta of 1.63, indicating that its share price is 63% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.25, indicating that its share price is 25% more volatile than the S&P 500. Is NTRA or HIMS more profitable? Hims & Hers Health has a net margin of 8.19% compared to Natera's net margin of -14.01%. Hims & Hers Health's return on equity of 10.97% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Natera-14.01% -26.23% -14.27% Hims & Hers Health 8.19%10.97%8.29% Do analysts recommend NTRA or HIMS? Natera currently has a consensus price target of $152.67, suggesting a potential downside of 5.69%. Hims & Hers Health has a consensus price target of $22.80, suggesting a potential downside of 12.98%. Given Natera's stronger consensus rating and higher possible upside, analysts plainly believe Natera is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natera 0 Sell rating(s) 0 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 3.00Hims & Hers Health 1 Sell rating(s) 8 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.41 Does the media prefer NTRA or HIMS? In the previous week, Hims & Hers Health had 18 more articles in the media than Natera. MarketBeat recorded 29 mentions for Hims & Hers Health and 11 mentions for Natera. Natera's average media sentiment score of 1.10 beat Hims & Hers Health's score of 0.48 indicating that Natera is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 11 Very Positive mention(s) 5 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Do institutionals & insiders hold more shares of NTRA or HIMS? 99.9% of Natera shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 7.6% of Natera shares are owned by insiders. Comparatively, 17.7% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community favor NTRA or HIMS? Natera received 440 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 68.82% of users gave Natera an outperform vote while only 38.61% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformNateraOutperform Votes47968.82% Underperform Votes21731.18% Hims & Hers HealthOutperform Votes3938.61% Underperform Votes6261.39% SummaryNatera beats Hims & Hers Health on 10 of the 18 factors compared between the two stocks. Ad Brownstone ResearchMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.So please click here to see the details because a lot of people could get rich. Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HIMS vs. The Competition Export to ExcelMetricHims & Hers HealthOffices & clinics of medical doctors IndustryMedical SectorNYSE ExchangeMarket Cap$5.72B$999.93M$5.14B$19.19BDividend YieldN/AN/A5.09%3.61%P/E Ratio59.5511.9189.9741.30Price / Sales4.611.311,116.2117.58Price / CashN/A42.9742.8921.28Price / Book16.277.884.785.32Net Income-$23.55M-$52.07M$120.23M$989.88M7 Day Performance-12.72%-5.17%-1.92%-3.54%1 Month Performance9.46%0.17%11.49%-3.68%1 Year Performance204.83%-18.32%30.57%12.14% Hims & Hers Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HIMSHims & Hers Health3.3845 of 5 stars$26.20-0.6%$22.80-13.0%+204.8%$5.72B$1.24B59.551,046Analyst ForecastInsider TradeNews CoverageNTRANatera2.0775 of 5 stars$168.91+1.4%$152.67-9.6%+168.5%$22.30B$1.53B-94.633,293Positive NewsGap DownFMSFresenius Medical Care3.4994 of 5 stars$24.04+1.6%$24.30+1.1%+8.6%$14.11B$19.24B19.791,358News CoveragePositive NewsGHGuardant Health4.1438 of 5 stars$35.23+1.4%$40.60+15.2%+16.0%$4.35B$692.26M-8.201,779News CoverageOPCHOption Care Health4.8653 of 5 stars$23.60+0.5%$30.14+27.7%-31.3%$4.02B$4.78B19.747,802Positive NewsSHCSotera Health3.59 of 5 stars$13.14-0.1%$16.08+22.4%-20.5%$3.72B$1.05B52.603,000Positive NewsVCYTVeracyte4.0636 of 5 stars$43.61+0.9%$41.13-5.7%+46.0%$3.38B$361.05M-288.13790Positive NewsBTSGBrightSpring Health Services2.3878 of 5 stars$18.95+2.1%$18.50-2.4%N/A$3.30B$10.59B-71.3835,000Analyst ForecastPositive NewsLFSTLifeStance Health Group1.6827 of 5 stars$7.80+8.8%$8.70+11.5%-4.1%$2.98B$1.21B-29.509,325Positive NewsGap UpSGRYSurgery Partners3.2422 of 5 stars$21.91+7.6%$36.56+66.8%-35.9%$2.78B$2.74B-42.4213,500CONConcentra Group Holdings ParentN/A$21.63+5.5%$28.50+31.8%N/A$2.75B$1.88B0.0011,000Gap Up Related Companies and Tools Related Companies NTRA Competitors FMS Competitors GH Competitors OPCH Competitors SHC Competitors VCYT Competitors BTSG Competitors LFST Competitors SGRY Competitors CON Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:HIMS) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HIMS Stock Alerts